Exhibit 99.1




November 3, 2020


       Pro Forma        
   November 3, 2020   Adjustments      As Adjusted 
         (unaudited)       (unaudited) 
Current asset - cash  $1,617,885   $-        $1,617,885 
Total current assets   1,617,885    -         1,617,885 
Cash held in trust account   101,000,000    15,000,000  (a)    116,150,000 
         450,000  (b)      
         (300,000) (c)      
Total Assets  $102,617,885   $15,150,000      $117,767,885 
Liabilities and Stockholders’ Equity                  
Deferred underwriting discount   3,500,000    525,000  (d)    4,025,000 
Total Liabilities   3,500,000    525,000       4,025,000 
Commitments and Contingencies                  
Common stock subject to possible redemption, 9,318,602 and 10,766,622 shares at redemption value, respectively   94,117,880    14,625,000  (e)    108,742,880 
Stockholders’ Equity:                  
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding   -      -         -   
Common stock, $0.0001 par value; 100,000,000 shares authorized; 4,056,398 and 4,153,378 shares issued and outstanding (excluding 9,318,602 and 10,766,622 shares subject to possible redemption, respectively)   406    150  (a)    416 
         5  (b)      
         (145) (e)      
Additional paid-in capital   5,000,060    14,999,850  (a)    5,000,050 
         449,995  (b)      
         (300,000) (c)      
         (525,000) (d)      
         (14,624,855) (e)      
Accumulated deficit   (461)   -         (461)
Total Stockholders’ Equity   5,000,005    -         5,000,005 
Total Liabilities and Stockholders’ Equity  $102,617,885   $15,150,000      $117,767,885 


The accompany notes are an integral part of the financial statement.




The accompanying unaudited Pro Forma Balance Sheet presents the Balance Sheet of New Beginnings Acquisition Corp. (the “Company”) as of November 3, 2020, adjusted for the closing of the underwriters’ over-allotment option and related transactions which occurred on November 9, 2020 and November 12, 2020 as described below.

The Company consummated its initial public offering (the “IPO”) of 10,000,000 units (the “Units”). Each Unit consists of one share of common stock, $0.0001 par value per share and one warrant to purchase one share of common stock. Each warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $100,000,000. The Company granted the underwriters in the IPO (the “Underwriters”) a 45-day option to purchase up to 1,500,000 additional Units to cover over-allotments, if any. On November 9, 2020, the Underwriters partially exercised the over-allotment option to purchase 1,000,000 Units (the “Over-Allotment Units”), and on November 12, 2020, the Underwriters fully exercised the over-allotment option to purchase the remaining 500,000 Over-Allotment Units, generating an aggregate of gross proceeds of $15,000,000, and incurred $300,000 in deferred underwriting fees.

Simultaneously with the closing of the exercise of the overallotment option, the Company completed the private sale (the “Private Placement”) of an aggregate of 45,000 private units (the “Private Units”) to New Beginnings Sponsor, LLC, a Delaware limited liability company (the “Sponsor”), at a purchase price of $10 per Private Units, generating gross proceeds of $450,000.

Upon closing of the IPO, the Private Placement, and the sale of the Over-Allotment Units, a total of $116,150,000 ($10.10 per Unit) was placed in a U.S.-based trust account, with Continental Stock Transfer & Trust Company acting as trustee.

Pro forma adjustments to reflect the exercise of the Underwriters’ over-allotment option and the sale of the Private Units described above are as follows:

  Pro Forma Entries     Debit       Credit  
(a) Cash held in trust account    $ 15,000,000          
      Common stock           $ 150  
      Additional paid-in capital           $ 14,999,850  
          To record sale of 1,500,000 Overallotment Units at $10.00 per Unit  
(b) Cash held in trust account    $ 450,000          
      Common stock           $ 5  
      Additional paid-in capital           $ 449,995  
          To record sale of 45,000 Private Units at $10.00 per Private Unit  
(c) Additional paid-in capital    $ 300,000          
      Cash held in trust account           $ 300,000  
          To record payment of cash underwriting fee   
(d) Additional paid-in capital    $ 525,000          
      Deferred underwriting discount           $ 525,000  
          To record additional deferred underwriting fee on overallotment option   
(e) Common stock    $ 145          
  Additional paid-in capital    $ 14,624,855          
      Common stock subject to possible redemption           $ 14,625,000  
          To record common stock out of permanent equity into mezzanine redeemable stock